WORK Medical Technology Group LTD 6-K, filed Feb 7, 2025
WORK Medical Technology Group LTD (WOK)
About this 6-K
WORK Medical Technology Group LTD filed this 6-K on February 7, 2025.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of February 2025
Commission File Number: 001-42256
WORK Medical Technology Group LTD
Floor 23, No. 2 Tonghuinan Road
Xiaoshan District, Hangzhou City, Zhejiang Province
The People’s Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Results of WORK Medical Technology Group LTD’s Annual General Meeting of Shareholders
The Annual General Meeting of Shareholders (the “Meeting”) of WORK Medical Technology Group LTD (the “Company”) was held at Floor 23, No. 2 Tonghuinan Road, Xiaoshan District, Hangzhou City, Zhejiang Province, China, on February 5, 2025, at 9:30 a.m. EST, with the ability given to the shareholders to join virtually via live audio webcast at http://www.virtualshareholdermeeting.com/WOK2025.
At the close of business on January 7, 2025, the record date for the determination of holders of the ordinary shares of the Company (the “Ordinary Shares”) entitled to vote at the Meeting, there were a total of 14,591,942 issued and outstanding Ordinary Shares, each being entitled to one (1) vote. At the Meeting, the holders of 8,572,632 Ordinary Shares of the Company were represented in person or by proxy, constituting a quorum.
At the Meeting, the shareholders of the Company adopted the following resolutions:
| 1. | An ordinary resolution to approve the re-election of Dr. Xiaoyang Li as a director of the Company (“Proposal No. 1); |
| 2. | An ordinary resolution to approve the re-election of Mr. Robert Brian Johnson as a director of the Company (“Proposal No. 2”); |
| 3. | An ordinary resolution to approve the re-election of Mr. Baiming Yu as a director of the Company (“Proposal No. 3”); |
| 4. | An ordinary resolution to approve the re-election of Mr. Shuang Wu as a director of the Company (“Proposal No. 4”); |
| 5. | An ordinary resolution to approve the re-election of Mr. Zhenguo Wu as a director of the Company (“Proposal No. 5”); |
| 6. | An ordinary resolution to approve the increase of the Company’s authorized share capital (“Proposal No. 6”); |
| 7. | An ordinary resolution to approve the re-designation and re-classification of the Company’s authorized share capital (“Proposal No. 7”); and |
| 8. | A special resolution to adopt an Amended and Restated Memorandum and Articles of Association of the Company (“Proposal No. 8”). |
The results of the vote at the Meeting for the resolutions were as follows:
| *Proposal | For | Against | Abstain | |||
| No. 1 | 8,572,632 | 0 | 0 | |||
| No. 2 | 8,572,632 | 0 | 0 | |||
| No. 3 | 8,572,620 | 0 | 12 | |||
| No. 4 | 8,572,632 | 0 | 0 | |||
| No. 5 | 8,572,632 | 0 | 0 | |||
| No. 6 | 8,572,603 | 1 | 28 | |||
| No. 7 | 8,572,615 | 1 | 16 | |||
| No. 8 | 8,572,629 | 1 | 2 |
| * | The numbers in this column correspond to those in the third paragraph of this report. |
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: February 7, 2025
| WORK Medical Technology Group LTD | ||
| By: | /s/ Shuang Wu | |
| Name: | Shuang Wu | |
| Title: |
Chief Executive Officer and | |
2